We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RPTX market cap is 168.73M. The company's latest EPS is USD -2.2236 and P/E is -1.80.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | ||
| Total Revenue | 18.2M | 5.68M | 30.25M | 2.16M | 13.05M |
| Operating Income | -19.63M | -34.68M | -12.26M | -38.42M | -30.87M |
| Net Income | -31.66M | -34.94M | -11.95M | -18.88M | -28.03M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Total Revenue | 135k | 7.6M | 131.83M | 51.13M |
| Operating Income | -54.3M | -108.66M | -19.8M | -116.22M |
| Net Income | -53.42M | -106.91M | -29.05M | -93.8M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | ||
| Total Assets | 364.08M | 336.31M | 301.59M | 286.41M | 253.9M |
| Total Liabilities | 84.56M | 85.06M | 56.17M | 53.04M | 41.82M |
| Total Equity | 279.52M | 251.24M | 245.41M | 233.37M | 212.08M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Total Assets | 357.09M | 368.72M | 364.08M | 253.9M |
| Total Liabilities | 70.26M | 80.29M | 84.56M | 41.82M |
| Total Equity | 286.83M | 288.42M | 279.52M | 212.08M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | ||
| Operating | 322k | -31.79M | -66.13M | -99M | -127.16M |
| Investing | -175.78M | -6.69M | 21.66M | 46.16M | 78.04M |
| Financing | 880k | 413k | 453k | 737k | 842k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Operating | -6.08M | -85.8M | 322k | -127.16M |
| Investing | -9.76M | -1.68M | -175.78M | 78.04M |
| Financing | 247.84M | 95.56M | 880k | 842k |
| Market Cap | 168.73M |
| Price to Earnings Ratio | -1.80 |
| Price to Sales Ratio | 3.31 |
| Price to Cash Ratio | 1.52 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 42.18M |
| Average Volume (1 week) | 278.15k |
| Average Volume (1 Month) | 236.79k |
| 52 Week Change | -66.78% |
| 52 Week High | 13.85 |
| 52 Week Low | 2.98 |
| Spread (Intraday) | 0.23 (5.44%) |
| Company Name | Repare Therapeutics Inc |
| Address |
7210 frederick-banting street saint-laurent, quebec H4S 2A1 |
| Website | https://www.reparerx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
